Drug Type Small molecule drug |
Synonyms Research programme: COVID-19 therapeutics - Arctoris/Insilico Medicine, Small molecule JAK inhibitors - Arctoris/Insilico Medicine |
Target |
Mechanism JAK inhibitors(Janus kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Arctoris Ltd.StartupInSilico Medicine Hong Kong Ltd.Startup |
Active Organization- |
Inactive Organization InSilico Medicine Hong Kong Ltd.StartupArctoris Ltd.Startup |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Discovery | HK | 01 Jul 2020 | |
Immune System Diseases | Discovery | GB | Arctoris Ltd.Startup | 01 Jul 2020 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |